What's the difference between CD80 and CD86?

被引:252
作者
Sansom, DM [1 ]
Manzotti, CN [1 ]
Zheng, Y [1 ]
机构
[1] Univ Birmingham, Sch Med, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England
关键词
D O I
10.1016/S1471-4906(03)00111-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28 and CD152 have crucial yet opposing functions in T-cell stimulation, in which CD28 promotes but CD152 inhibits T-cell responses. Intriguingly, they share two ligands, CD80 and CD86, but at present there is no clear model for understanding whether a ligand will promote or inhibit responses. Current perceptions are based around the concept that CD86 is the initial co-stimulatory ligand based on its more abundant and earlier expression pattern; CD80 has a role following antigen-presenting-cell activation. We describe an alternative view in which CD80 is the initial ligand, responsible for maintaining aspects of immune tolerance through interactions with CD152. These inhibitory functions can then be over-ridden by the upregulation of CD86 on dendritic cells as a result of inflammatory stimuli, leading to immune activation.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 58 条
[51]   Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma [J].
Tarte, K ;
Lu, ZY ;
Fiol, G ;
Legouffe, E ;
Rossi, JF ;
Klein, B .
BLOOD, 1997, 90 (09) :3482-3495
[52]   CD4+CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade [J].
Taylor, PA ;
Noelle, RJ ;
Blazar, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1311-1317
[53]   The emerging role of CTLA-4 as an immune attenuator [J].
Thompson, CB ;
Allison, JP .
IMMUNITY, 1997, 7 (04) :445-450
[54]   CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen [J].
Walker, LSK ;
Ausubel, LJ ;
Chodos, A ;
Bekarian, N ;
Abbas, AK .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6202-6209
[55]   CTLA-4 ligation blocks CD28-dependent T cell activation [J].
Walunas, TL ;
Bakker, CY ;
Bluestone, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2541-2550
[56]   LYMPHOPROLIFERATIVE DISORDERS WITH EARLY LETHALITY IN MICE DEFICIENT IN CTLA-4 [J].
WATERHOUSE, P ;
PENNINGER, JM ;
TIMMS, E ;
WAKEHAM, A ;
SHAHINIAN, A ;
LEE, KP ;
THOMPSON, CB ;
GRIESSER, H ;
MAK, TW .
SCIENCE, 1995, 270 (5238) :985-988
[57]   CD28-independent costimulation of T cells in alloimmune responses [J].
Yamada, A ;
Kishimoto, K ;
Dong, VM ;
Sho, M ;
Salama, AD ;
Anosova, NG ;
Benichou, G ;
Mandelbrot, DA ;
Sharpe, AH ;
Turka, LA ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :140-146
[58]   Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling [J].
Zhang, XW ;
Schwartz, JCD ;
Almo, SC ;
Nathenson, SG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2586-2591